US Stock MarketDetailed Quotes

CLSD Clearside Biomedical

Watchlist
  • 1.110
  • +0.020+1.83%
Close Nov 12 16:00 ET
  • 1.140
  • +0.030+2.68%
Post 17:20 ET
82.97MMarket Cap-2220P/E (TTM)

About Clearside Biomedical Company

Clearside Biomedical, Inc. is a biopharmaceutical company, which delivers therapies to the back of the eye through the suprachoroidal space. Its pipeline include CLS-AX, Integrin Inhibitor, and gene therapy. The company was founded by Samir Kumar Patel, Vladimir Zarnitsyn, Mark Prausnitz, Daniel H. White, and Henry F. Edelhauser in May 2011 and is headquartered in Alpharetta, GA.

Company Profile

SymbolCLSD
Company NameClearside Biomedical
Listing DateJun 2, 2016
Issue Price7.00
Founded2011
CEODr. George Lasezkay, J.D.,Pharm.D.
MarketNASDAQ
Employees30
Fiscal Year Ends12-31
Address900 North Point Parkway,Suite 200
CityAlpharetta
ProvinceGeorgia
CountryUnited States of America
Zip Code30005
Phone1-678-270-3631
Websitehttp://www.clearsidebio.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. George Lasezkay, J.D.,Pharm.D.
  • President, Chief Executive Officer and Director
  • 1.54M
  • Victor Chong, M.D.
  • Chief Medical Officer
  • --
  • Charles A. Deignan
  • Chief Financial Officer and Principal Accounting Officer
  • 854.41K
  • William D. Humphries
  • Chairman of the Board
  • 91.71K
  • Anthony S. Gibney
  • Director
  • --
  • Jeffrey L. Edwards
  • Independent Director
  • 88.58K
  • Dr. Christy L. Shaffer,PhD
  • Independent Director
  • 86.08K
  • Dr. Benjamin R. Yerxa,PhD
  • Independent Director
  • 88.58K
  • Richard J. Croarkin
  • Independent Director
  • 91.08K
  • Clay B. Thorp
  • Independent Director
  • 96.08K
  • Dr. Nancy J. Hutson, PhD
  • Independent Director
  • 85.46K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data